Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- AOBC -10.2%, EXFO -1%
Other news:
- CARA -29% (announces top-line results from a Phase 2b trial of an oral tablet formulation of CR845 in patients with osteoarthritis of the knee or hip; Statistically significant 39 percent reduction in mean joint pain score in hip patients at eight weeks with 5.0 mg dose)
- CIDM -26.4% (following conference call after the close on recent discovery for pancreatic cancer and business update)
- MBRX -24.2% (conference call to discuss recent new discovery for pancreatic cancer and business update)
- DEST -23.3% (following FY17 results from merger partner Orchestra Prémaman)
- RGR -4.2% (following AOBC earnings)
- ALKS -3.3% (announces preliminary topline results from ENLIGHTEN-1, an investigational, novel, once-daily, oral atypical antipsychotic drug candidate for the treatment of schizophrenia)
- CBK -3% (CFO & COO Pete Michielutti resigns effective July 14 to accept another opportunity)
- CVM -2.1% (disclosed the FDA requested that three additional changes be made to Multikine Investigator Brochure submitted on June 2)
- PCRX -1.3% (determined to discontinue all future production of DepoCyt)
Analyst comments:
- VIPS -2% (downgraded to Hold from Buy at Deutsche Bank)
- WUBA -1.9% (downgraded to Underweight at Morgan Stanley)
- BLUE -1.4% (downgraded to Neutral from Buy at BTIG Research)
Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- NKE +5.7%, (also confirms during earnings conference call a new pilot program with Amazon (AMZN); in the early stages), CAFD +3.7%, (Sponsors' strategic review of Partnership interests continuing ), MU +1.3%
Select Nike related names showing strength:
- FL +1.4%, UAA +1.3%, FINL +0.6%, LULU +0.5%
Other news:
- SKLN +42% ( provides investor update in letter to shareholders; actively engaged in the process of assembling distribution network)
- WMAR +30.9% (West Marine to be acquired by Monomoy Capital Partners for $12.97 per share (halted))
- CHFS +17.6% (continued strength)
- HAIN +7.1% (Engaged Capital discloses 9.9% active stake)
- TSLA +1.1% (CEO Elon Musk tweeted about upcoming news on Model 3 that will be out Sunday)
- BAC +0.9% (Berkshire Hathaway (BRK.A/B) says plans to exercise warrants to acquire 700 mln shares of Bank of America Common Stock)
Analyst comments:
- DERM +4.4% (initiated with a Outperform at Evercore ISI)
- RIO +2.3% (upgraded to Buy from Underperform at BofA/Merrill)
- COG +1.7% (upgraded to Buy from Neutral at BofA/Merrill)
- GFI +0.9% (upgraded to Neutral from Sell at Goldman)
- AXGN +0.6% (initiated with Overweight ratings at Cantor Fitzgerald)
E*Trade, in Bid to Survive, Returns to Its Roots
Online brokerage pioneer targets active traders in ad campaign, sets ambitious growth goals in last-ditch turnaround effort
E*Trade Financial Corp.’s board has delivered an ultimatum to its new chief executive: Clearly define the company’s future by the end of next year or face a possible sale, executives at the discount brokerage say.
In delivering the mandate, the board is asking Karl Roessner, E*Trade’s chief since September, to reinvigorate the core brokerage business and achieve a revival that has largely eluded the six CEOs who preceded him after the company’s near implosion during the financial crisis.
“We have to get there...and make sure we can grow this [business] organically,” Mr. Roessner, who is 49, a former deal attorney and had been company’s general counsel since 2009, said in an interview. “We have to turn around that stagnation from the top of the house.”
Mr. Roessner’s plan is simple: return the company to its roots as an irreverent fintech firm. The 35-year-old brokerage is refreshing its trading technology, deepening its derivative-trading capabilities, and embarking on an advertising campaign to appeal to investors’ aspirational desires.
But E*Trade’s pursuit of traders and commissions is going against the tide in an investing landscape that has been upended since the company’s heyday in the 1990s and early 2000s. Its biggest rivals, including Charles Schwab Corp. and TD Ameritrade Inc., have moved away from relying on commissions, which are at record lows, and instead pursued fee-based accounts. Smaller competitors such as Scottrade Financial Services Inc. have decided they couldn’t go it alone and have sold themselves. And startups like Robinhood Corp. have captured younger investors with commission-free trading.
Besides that, E*Trade is trying to court investors at a time when many have taken to simply matching the market’s performance amid eight years of rising stock prices. Some $1.2 trillion has been withdrawn from actively managed U.S. stock funds since the start of 2007 through March, according to Morningstar Inc. Nearly the same amount, $1.1 trillion, has moved into passive U.S. stock funds that track broad indexes such as the S&P 500.
Shares of E*Trade have rallied nearly 9% so far this year to $37.68, keeping its gains close to rival Schwab, which is also up around 9% this year. TD Ameritrade, meanwhile, is down about 2%. E*Trade is still trading well below its $241 share price in mid-2007 and its peak of $577 in 1999.
“E*Trade is smaller than some of its larger competitors, so they’re going to have to keep looking for ways to be disruptive,” said Devin Ryan, a brokerage analyst with JMP Securities.
E*Trade is targeting investors who trade 30 times a month or more on their own and like derivative plays, such as options, believing that its rivals haven’t been catering to them much. Last year, it bought Aperture New Holdings Inc., the parent of online broker OptionsHouse LLC, for $725 million, to boost its derivative offerings and overhaul its trading platform.
Attracting those types of investors would bring Mr. Roessner closer to meeting the board’s growth expectations. By the end of next year, Mr. Roessner says he has to boost the firm’s net new brokerage asset and account growth rates by 2% to 3% each, while increasing the firm’s mix of derivatives trades and amount of managed products, which includes services offered through its automated robo adviser.
If E*Trade falls short of those goals, the board will then consider strategic alternatives, including a possible sale, Mr. Roessner said.
“Our decision to present specific growth goals, to be achieved within an aggressive timeline, was questioned by some,” said Rodger Lawson, executive chairman of E*Trade’s board. “But as a board we had great faith in the inherent but underused power of the E*Trade brand.”
E*Trade has already approached some of those benchmarks, pushing its net new brokerage asset growth rate to 6.1% in the first quarter of this year from 3.8% last year, while net new brokerage account growth has more than doubled to 6.7%.
Analysts say E*Trade is moving in the right direction, but the brokerage industry’s challenges can make further gains harder to obtain.
Mr. Roessner acknowledges as much. “These are early successes,” he said. “We have to show consistently that we can grow this.”
This turnaround effort begins the latest chapter for the brokerage pioneer that upended Wall Street’s traditional investing model with the first online trade in 1983. Along the way, the company came to be known as a poster child for a day-trading culture that was spawned by 1990s tech-stock boom as well as its high-profile Super Bowl ads featuring a dancing monkey and talking babies.
When the tech-stock bubble burst in 2000, brokerages, including E*Trade, suffered as burned investors looked for safety. E*Trade turned to banking to steady its revenue and amassed billions of dollars in toxic subprime mortgages on its balance sheet—a move that proved near fatal as the financial system started to blow up in 2007.
E*Trade suffered a $1.44 billion loss in 2007—its worst year in its history after reporting a $628.9 million profit in 2006.
In the years since, E*Trade attempted to stabilize itself, twice leaning on its largest investor at the time, hedge-fund giant Citadel LLC, for help.
Over that time, the company lost its competitive edge, analysts and executives at E*Trade say, as its technology grew stale and rivals, both new and old, kept a step ahead.
“They were really in a difficult spot,” JMP’s Mr. Ryan said. “That created a situation where the firm was inward focused so they could live to fight another day.”
If the turnaround falls short of the board’s expectations, analysts say, E*Trade’s prospects as an M&A target are promising, with more than $37 billion in deposits and $336 billion in assets spread across 3.5 million accounts. “It’s a firm that would be attractive for a lot of reasons,” Mr. Ryan said. “The most obvious attraction is adding scale.”
*DJ E*Trade Board Will Consider Alternatives, Including Sale, If Metrics Not Met: Executives
NIKE: Color on Quarter
- Telsey Advisory Group raises their NKE tgt to $63 from $62. 4QF17 unfolded in a very similar fashion to 3QF17 with an EPS beat that was driven by well-managed SG&A and a lower tax rate. Futures also came in light once again, though they believe that has become less of an issue as Nike's sales outpace futures at a growing rate (800 bps in 4QF17 vs. 500 bps last quarter). Looking ahead, the co cautioned that North America remains choppy and guided to slight contraction in the first half of the year, as it deliberately exits less-productive and less-differentiated distribution. However, the full-year guidance was better than whisper numbers, which had fallen significantly, and mgmt was able to talk about an inflection in Basketball and strong results from recently-launched product innovations that should drive growth in 2HF18. The retail environment is tough, but they believe Nike is on the right path and want to be involved ahead of a potential turnaround.
- Stifel: Against a backdrop of low expectations, NIKE delivered solid FY4Q results packaged with a notable emphasis of a strategic shift to direct consumer engagement. They found the coherent discussion of strategic direction encouraging and see NIKE uniquely positioned to execute to a more direct model which they expect translates to growth, margin improvement, and strengthening ROIC longer-term. While market concerns around challenges in the North American market may limit multiple expansion near-term, they remain confident in their Buy rating.
- FBR & Co notes co beat Q4 results and guided Q1 below. Futures were reported below expectations with currency-neutral total futures of 0% (vs. consensus of +1.5%). Amid the Amazon pilot, they believe NKE will maintain its rigorous product segmentation and reserve premium products for sale through its own website and select retail partners. They like Nike's innovation pipeline, int'l runway, and LT margin catalysts, but they remain on the sidelines and look for improved rev growth, margin execution, and lower inventory growth.
Early premarket gappers
Gapping up:
- WMAR +30.9%, CHFS +29.6%, SKLN +26%, NKE +6.6%, NXTD +5.6%,DERM +4.4%, HAIN +3.8%, MU +2.2%, CAFD +2.1%, ASML +2%, FL+1.4%, GOLD +1.4%, UAA +1.3%, BAC +1.2%, AMD +1.2%, TSLA +1%,NFLX +0.7%, NVDA +0.7%, FINL +0.6%
Gapping down:
- CARA -29.5%, CIDM -26.4%, MBRX -14.1%, AOBC -9.4%, RGR -4.2%,ALKS -3.3%, CBK -3%, CVM -2.1%, PCRX -1.3%, EXFO -1%
RTRS - ACCORHOTELS ACCP.PA CEO SAYS GROUP IN "EXTREMELY ACTIVE" DISCUSSIONS WITH POTENTIAL INVESTORS OVER HOTELINVEST, CANNOT GIVE MORE DETAILS
MainFirst Pre Mkt Indications
*VIVENDI-Says could exit Ubisoft to focus on other targets-Figaro...-0.5%
*ROCHE-Polatuzumab Vedotin gets priority medicines designation......+0.25%
*LUNDBECK-Gets ok for parkinson drug Azilect in China - Press.......+0.25%
*JCDECAUX-Wins 20 yr bus,tram shelter ad contract for Helsinki......+0.25%
*TECHNICOLOR-Cuts FY Ebitda 420-480m(460-520),memory costs rise.....-5%
*LAFARGEHOLCIM-Chile Court approves sale of Polpaico stake €220m....U/C
*ADIDAS-Read across from Nike +8% a/hrs,top line +ve,o/l wk.........+0.5%
*EON-To use nuclear fuel tax 4 bal sheet,no special div/acq's.......+0.5%
*HEIDELBERGER DRUCK-Targets double-digit Ebit margin says CEO.......+1%
*ACCOR-France has 1.3m fewer tourists in 2016 says Le Figaro........-1%
Investec UK & Euro Pre Mkt Indications
UK
* GAME DIGITAL-Update.WARNING.Ebita 'Substantially' below prev.exp's.......-20%
* JOHN LAING-PreClose.Trading in line. Pipeline remains +ve................unch
* SERCO-Update.Mkt remains unpredictable but reits guidance.................-1%
* SHANTA GOLD-Tanzanian legal changes.1% clearing fee on exported minerals..-5%
* TRINITY MIRROR-Update.#'s i/l. Trading remains voltaile but FY on track..unch
* WS ATKINS-last day of dealing today, we expect to have interest.
Euro
* ADIDAS-Nike rose 8% in afterhours trading on positive outlook...........+1.5%
* HEIDELBERGER DRUCK-targets double-digit ebit margin(BZ)...................+2%
* TECHNICOLOR-cuts FY ebitda guidance by 8% on rising memory prices.........-5%
* UNIPOL-transfers €3bn of impaired loans to new co., takes €780m charge....+1%
* RWE-looking to buy power plants to profit from higher prices(FAZ).........U/C
* VIVENDI-could exit UBISOFT(-2%) stake to focus on other target(Figaro)..-0.5%